{"id":"https://openalex.org/W4404065645","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.0508","title":"508 A novel in vitro assay to evaluate the potency of anti-PD-1 and anti-PD-L1 drugs in NSCLC","display_name":"508 A novel in vitro assay to evaluate the potency of anti-PD-1 and anti-PD-L1 drugs in NSCLC","publication_year":2024,"publication_date":"2024-11-01","ids":{"openalex":"https://openalex.org/W4404065645","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.0508"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2024-sitc2024.0508","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.0508","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-sitc2024.0508","pdf_url":null,"source":{"id":"https://openalex.org/S4363604233","display_name":"Regular and Young Investigator Award Abstracts","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1136/jitc-2024-sitc2024.0508","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Xuefei Yan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xuefei Yan","raw_affiliation_strings":["Crown Bioscience, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crown Bioscience, Inc., San Diego, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088252046","display_name":"Shiqi Guo","orcid":"https://orcid.org/0000-0002-9287-4041","observed_orcids":["https://orcid.org/0000-0002-9287-4041"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shiqi Guo","raw_affiliation_strings":["Crown Bioscience, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crown Bioscience, Inc., San Diego, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jiawei Meng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jiawei Meng","raw_affiliation_strings":["Crown Bioscience, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crown Bioscience, Inc., San Diego, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Meng Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meng Zhang","raw_affiliation_strings":["Crown Bioscience, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crown Bioscience, Inc., San Diego, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Haijuan Yu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haijuan Yu","raw_affiliation_strings":["Crown Bioscience, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crown Bioscience, Inc., San Diego, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109256899","display_name":"Lin Jie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jie Lin","raw_affiliation_strings":["Crown Bioscience, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crown Bioscience, Inc., San Diego, CA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101870604","display_name":"Jun Zhou","orcid":"https://orcid.org/0000-0002-4176-976X","observed_orcids":["https://orcid.org/0000-0002-4176-976X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jun Zhou","raw_affiliation_strings":["Crown Bioscience, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Crown Bioscience, Inc., San Diego, CA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A572","last_page":"A572"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.7450000047683716},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.7459999918937683},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.9800000190734863},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.8650000095367432},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":1.0},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9589999914169312},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.6980000138282776},{"id":"https://openalex.org/keywords/t-cell-co-culture","display_name":"T cell co-culture","score":0.7200000286102295},{"id":"https://openalex.org/keywords/tumor-cell-killing","display_name":"tumor cell killing","score":0.8040000200271606},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.781000018119812},{"id":"https://openalex.org/keywords/tumor-organoids","display_name":"tumor organoids","score":0.4230000078678131},{"id":"https://openalex.org/keywords/live-cell-imaging","display_name":"live-cell imaging","score":0.5879999995231628},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.5260000228881836},{"id":"https://openalex.org/keywords/t-cells","display_name":"T cells","score":0.3230000138282776}],"concepts":[{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.7761386036872864},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.6603142023086548},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5182502269744873},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41084516048431396},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33866339921951294},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10569995641708374}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2024-sitc2024.0508","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.0508","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-sitc2024.0508","pdf_url":null,"source":{"id":"https://openalex.org/S4363604233","display_name":"Regular and Young Investigator Award Abstracts","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2024-sitc2024.0508","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.0508","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-sitc2024.0508","pdf_url":null,"source":{"id":"https://openalex.org/S4363604233","display_name":"Regular and Young Investigator Award Abstracts","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4387497383","https://openalex.org/W2948807893","https://openalex.org/W2899084033","https://openalex.org/W2778153218","https://openalex.org/W2748952813","https://openalex.org/W1531601525","https://openalex.org/W4391375266","https://openalex.org/W3031052312","https://openalex.org/W4389568370","https://openalex.org/W3032375762"],"abstract_inverted_index":{"Background":[0],"Programmed":[1],"cell":[2,14,122,158,164,193,237,270,302,326,333,373,381],"death":[3],"protein":[4],"1":[5],"(PD-1),":[6],"expressed":[7],"by":[8,116,182,239,337],"activated":[9,104,315,365],"T":[10,13,44,107,140,196,214,366],"cells,":[11,42,45,126,199,230],"modulates":[12],"function":[15],"upon":[16],"binding":[17],"to":[18,36,46,57,75,81,323,349,391],"its":[19],"ligands,":[20],"PD-L1":[21,119],"and":[22,48,111,135,177,197,262,306],"PD-L2,":[23],"found":[24],"on":[25],"tumor":[26,70,91,229,236,269,325,332,360,372],"cells":[27,92,108,141,208,215,361,367],"or":[28,54,93,129,139,154,167,171,223,355,362,368,383],"antigen-presenting":[29],"cells.":[30,97],"The":[31,328],"goal":[32],"of":[33,40,85,90,146,151,188,221,251,335,353],"immunotherapy":[34],"is":[35],"restore":[37],"the":[38,83,149,173,191,219,248,351,370,397],"ability":[39],"immune":[41,96],"particularly":[43],"recognize":[47],"eliminate":[49],"cancer.":[50],"Antibodies":[51],"targeting":[52,396],"PD-1":[53,112,203],"PD-L1,":[55],"aim":[56],"block":[58],"their":[59],"inhibitory":[60],"signaling,":[61],"have":[62,341],"demonstrated":[63,234],"effective":[64],"in":[65,68,78,88,133,148,218,227,241,344,347],"vivo":[66],"efficacy":[67],"certain":[69],"models.":[71],"This":[72,386],"study":[73],"aims":[74],"establish":[76],"an":[77,143,343],"vitro":[79,345],"assay":[80,346,387],"assess":[82],"effects":[84],"PD-1/PD-L1":[86,398],"blockade":[87],"co-cultures":[89],"organoids":[94,363],"with":[95,105,137,162,200,213,247,288,293,314,319,364],"Methods":[98],"PBMCs":[99,138,316],"from":[100],"healthy":[101],"donors":[102],"were":[103,109,131,195,211,312],"stimuli,":[106],"isolated":[110],"expression":[113],"was":[114,160,175,180,285],"detected":[115],"flow":[117],"cytometry.":[118],"expressing":[120],"non-small":[121],"lung":[123],"cancer":[124],"(NSCLC)":[125],"NCI-H2228,":[127],"NCI-H1975":[128],"LU5178E-lucg":[130],"seeded":[132],"microplates":[134],"treated":[136],"at":[142],"E:T":[144],"ratio":[145],"1:1":[147],"presence":[150,220],"anti-PD-1":[152,222,261,354],"pembrolizumab":[153],"anti-PD-L1":[155,265,356],"atezolizumab.":[156],"Tumor":[157],"viability":[159],"analyzed":[161],"live":[163,380],"imaging":[165,382],"(IncuCyte)":[166],"luminescence.":[168],"After":[169,185],"72h":[170],"120h,":[172],"supernatant":[174],"collected":[176],"IFN\u03b3":[178,283],"concentration":[179],"measured":[181,322],"ELISA.":[183],"Results":[184],"three":[186],"days":[187],"PBMC":[189],"activation,":[190],"major":[192],"populations":[194],"NK":[198],"significantly":[201],"higher":[202],"expression.":[204],"CellTracker":[205],"red-labeled":[206],"PD-L1+":[207,301,307],"(HLA-A*02:01,":[209,216,310],"03:01)":[210],"co-cultured":[212],"26:01)":[217],"isotype.":[224],"A":[225,254],"change":[226],"viable":[228],"quantified":[231],"via":[232,379],"IncuCyte,":[233],"enhanced":[235,331],"killing":[238,246,334,374],"anti-PD-1,":[240],"a":[242],"dose-dependent":[243,287],"manner":[244],"(30%":[245],"highest":[249,294],"dose":[250,295],"10":[252,296],"\u00b5g/mL).":[253],"luciferase":[255],"readout":[256,321],"offered":[257],"similar":[258],"results":[259,329],"for":[260],"indicated":[263],"that":[264,281],"could":[266,388],"also":[267,286],"enhance":[268],"killing,":[271],"albeit":[272],"not":[273],"as":[274,276],"strongly":[275],"anti-PD-1.":[277,338],"Cytokine":[278],"analysis":[279],"showed":[280,330],"increased":[282],"secretion":[284],"anti-PD1":[289],"treatment":[290],"(2.48":[291],"fold":[292],"\u00b5g/mL":[297],"anti-PD-1).":[298],"An":[299],"additional":[300],"line":[303],"(HLA-A*01:01,":[304],"01:01)":[305],"organoid":[308],"model":[309],"02:01)":[311],"tested":[313],"(HLA-A*23:17,":[317],"30:01),":[318],"luminescence":[320,384],"estimate":[324],"viability.":[327],"~10%-30%":[336],"Conclusions":[339],"We":[340],"established":[342],"NSCLC":[348],"evaluate":[350,392],"potency":[352],"drugs.":[357],"By":[358],"co-culturing":[359],"PBMCs,":[369],"direct":[371],"effect":[375],"can":[376],"be":[377,389],"evaluated":[378],"reading.":[385],"used":[390],"future":[393],"biologic":[394],"molecules":[395],"pathway.":[399]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}